Collagen VI is an extracellular matrix protein with broad distribution in several tissues. Although Col6a1 is expressed by Schwann cells, the role of collagen VI in the peripheral nervous system (PNS) is yet unknown. Here we show that Schwann cells, but not axons, contribute to collagen VI deposition in peripheral nerves. By using Col6a1-null mice, in which collagen VI deposition is compromised, we demonstrate that lack of collagen VI leads to increased myelin thickness (P<0.001) along with 60 -130% up-regulation in myelin-associated proteins and disorganized C fibers in the PNS. The hypermyelination of PNS in Col6a1 ؊/؊ mice is supported by alterations of signaling pathways involved in myelination, including increase of P-FAK, P-AKT, P-ERK1, P-ERK2, and P-p38 (4.15, 1.67, 2.47, 3.34, and 2.60-fold, respectively) and reduction of vimentin (0.49-fold), P-JNK (0.74-fold), and P-c-Jun (0.50-fold). Pathologically, Col6a1 ؊/؊ mice display an impairment of nerve conduction velocity and motor coordination (P<0.05), as well as a delayed response to acute pain stimuli (P<0.001), indicating that lack of collagen VI causes functional defects of peripheral nerves. Altogether, these results indicate that collagen VI is a critical component of PNS contributing to the structural integrity and proper function of peripheral nerves.-Chen, P., Cescon, M., Megighian, A., Bonaldo, P. Collagen VI regulates peripheral nerve myelination and function. FASEB J. 28, 000 -000 (2014). www.fasebj.org
In the peripheral nervous system (PNS), myelin is produced by Schwann cells and plays a crucial role for the transmission of electric impulse. In the adult organism, myelinating Schwann cells envelop larger axons in a myelin sheath at a 1:1 ratio (1, 2), whereas nonmyelinating Schwann cells ensheath multiple smaller axons, known as C fibers (3) . Altered myelination in the PNS is related to a variety of neurological disorders, such as hypomyelination in hereditary neuropathy with liability to pressure palsies (4), Charcot-Marie-Tooth disease (5), Dejerine-Sottas syndrome and congenital hypomyelination (6) , and hypermyelination in adrenomyeloneuropathy (7) .
Myelination in the PNS is regulated by extracellular matrix (ECM) molecules in the basement membrane that assembles at the surface of Schwann cell/axon units (8, 9) . Coculture of Schwann cells and neurons demonstrated that basement membrane assembly is required for Schwann cells myelination in vitro (10) . Genetic studies showed that basement membrane molecules and their receptors, such as ␤1 integrin (11) and laminins (1, 12, 13) , are essential for proper myelination and/or motor function in the PNS. Collagens, the prominent components of ECM, also appear to be involved in myelination. Genetic studies demonstrated that lack of the ␣4(V) collagen subunit significantly inhibits Schwann cell myelination in vitro (14) , and ablation of collagen XV in mice causes polyaxonal myelination and hypomyelination in the PNS (8) .
Collagen VI is a peculiar component of the collagen superfamily made of 3 genetically distinct chains and abundantly deposited in the basement membrane of a variety of tissues, such as skeletal muscles (15, 16) , skin (17) , and peripheral nerves (18) . Collagen VI exerts a neuroprotective activity in the central nervous system, where it has been shown to inhibit the neurotoxicity of A␤ peptides (19) and of ultraviolet irradiation (20) . Although our previous studies demonstrated that Col6a1 is expressed by Schwann cells (21) , the role of collagen VI in the PNS remains largely unknown. Here, we utilized Col6a1 Ϫ/Ϫ mice, where a targeted inactivation of the gene coding for the ␣1(VI) chain prevents the assembly and secretion of collagen VI in the ECM (22, 23) to demonstrate that collagen VI is crucial for the structural integrity of PNS and for peripheral nerve function.
MATERIALS AND METHODS

Animals
Col6a1
ϩ/ϩ (wild-type) and Col6a1 Ϫ/Ϫ mice in the C57BL/6 background (22, 23) were used in this study. Pregnant Sprague-Dawley rats were purchased from Harlan Laboratories (Udine, Italy). Native collagen VI was purified from newborn mice as described previously (23) . Animal procedures were approved by the Ethics Committee of the University of Padova and authorized by the Italian Ministry of Health.
Cell cultures
The RT4-D6P2T Schwann cell line was purchased from American Type Culture Collection (LGC Standards S.r.l., Sesto San Giovanni, Italy) and cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Paisley, UK) containing 10% fetal bovine serum (Gibco), 0.2 M l-glutamine (Invitrogen, Carlsbad, CA, USA), and 1:100 penicillin-streptomycin (Invitrogen). RT4-D6P2T cells were treated with purified collagen VI to analyze protein expression by Western blot. Primary Schwann cell cultures were isolated from newborn rat sciatic nerves as described previously (24, 25) and grown for 48 h in DMEM/F12 medium (Life Technologies, Gaithersburg, MD, USA) supplemented with 10% fetal calf serum (Gibco) and 1:100 penicillin-streptomycin (Invitrogen). Cytosine arabinoside (Ara-C; 10 M) was added, and the treatment was prolonged for further 48 h, resulting in Schwann cell cultures that were 99% pure and were used for further studies.
Histology
After mice were perfused with 4% paraformaldehyde (PFA), sciatic nerves were dissected and postfixed in 2% glutaraldehyde for 24 h at 4°C. Samples were osmicated in 2% osmium tetroxide for 2 h at room temperature, dehydrated in ascending acetone, and embedded in Epon E812 resin (Sigma, St. Louis, MO, USA). Semithin sections (0.5 m) were cut using an Ultracut 200 microtome (Leica, Wetzlar, Germany), and stained with alkaline toluidine blue. Axon numbers were analyzed on 8 sections/sciatic nerve, and the g ratio of all axons was measured using ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA) as described previously (8) . For electron microscopy, ultrathin sections (80 nm) were cut, mounted on copper grids, and stained with uranyl citrate and lead citrate. Grids were observed and photographed on a FEI Tecnai 12 transmission electron microscope (FEI, Hillsboro, OR, USA). For the internodal length measurement, sciatic nerves were dissected, fixed in 2% glutaraldehyde for 1 h at room temperature, washed in 0.12 M sodium phosphate buffer 3 times, incubated in 1% osmium for 2 h at room temperature, transferred into 66% glycerol overnight at room temperature, and then transferred into 100% glycerol at 4°C. Nerves were teased using acupuncture needles, and the images were obtained by light microscope (Leica). The internodal length was measured using ImagePro Plus 6.0 software (Media Cybernetics, Rockville, MD, USA).
Terminal deoxynucleotidyl transferase dUTP-mediated nickend labeling (TUNEL)
TUNEL assay was performed using the Dead End Fluorometric In Situ Apoptosis Detection System (Promega, Madison, WI, USA). Cross-sections of sciatic nerves were permeabilized in 100% methanol for 10 min at Ϫ20°C. Slides were dried, washed in PBS 3 times, and incubated in proteinase K for 5 min at room temperature. After being washed 3 times in PBS, samples were incubated with equilibration buffer for 10 min and then incubated with a buffer containing fluorescent nucleotides, terminal deoxynucleotidyl transferase (TdT), and Hoechst for 1 h at 37°C. The reaction was then blocked with SSC solution (300 mM NaCl, 30 mM sodium citrate). After being washed 3 times in PBS, slides were mounted using 80% glycerol. TUNEL-positive cells were analyzed on 8 sections/sciatic nerve using ImageJ software.
Immunofluorescence
After mice were perfused with 4% PFA, sciatic nerves were removed and postfixed for 4 h at 4°C. Tissues were then transferred into 30% sucrose overnight for cryoprotection. Cross and longitudinal sections of sciatic nerves at 10 m were cut in a cryostat (Leica). For nodal integrity analysis, sciatic nerves were dissected and fixed in 4% PFA for 4 h at 4°C, washed in several changes of PBS, and then teased on 3-aminopropyltriethoxysilane (TESPA; Sigma)-coated slides. After blocking with 10% goat serum for 1 h, sections were incubated with primary antibodies (1:200) for 2 h at room temperature or overnight at 4°C. Primary antibodies against the following proteins were used: CD45, CD68 (rat monoclonal; AbD Serotec, Raleigh, NC, USA); cleaved caspase-3 (rabbit polyclonal; Cell Signaling, Danvers, MA, USA); collagen VI (rabbit polyclonal; Fitzgerald, Acton, MA, USA); contactin-associated protein (Caspr; mouse monoclonal, a kind gift of Elior Peles, Weizmann Institute of Science, Rehovot, Israel); ezrin (rabbit polyclonal; Upstate, Lake Placid, NY, USA); Kv1.1 (rabbit polyclonal; Alomone Labs, Jerusalem, Israel.); myelin basic protein (MBP, rat monoclonal; Abcam, Cambridge, MA, USA); Nav1.6 (rabbit polyclonal, a kind gift of James S. Trimmer, University of California, Davis, CA, USA); nerve growth factor receptor p75 (NGFR p75, rabbit polyclonal; Millipore; Billerica, MA); neurofilament (mouse monoclonal; Covance, Chantilly, VA, USA); peripherin (rabbit polyclonal; Novus, St. Charles, MO, USA); S100 (rabbit polyclonal; Abcam). Guinea pig polyclonal ␣3(VI) collagen antibody (26) and rabbit polyclonal AS-72 specific for murine collagen VI antibody (27) were kindly provided by Raimund Wagener (Universität zu Köln, Cologne, Germany) and Alfonso Colombatti (Centro di Riferimento Oncologico di Aviano, Aviano, Italy), respectively. The sections were then transferred to secondary antibodies (1:200) and Hoechst 33258 (Sigma) for 1 h at room temperature. The following secondary antibodies were used: anti-mouse CY3, anti-rat CY3, anti-rabbit CY2, anti-rabbit CY3, anti-guinea-pig CY2 (Jackson Immunoresearch, West Grove, PA, USA); and antirabbit IRIS5 (Cyanine Technologies, Turin, Italy). After being washed 3 times in PBS, slides were mounted using 80% glycerol.
Western blotting
Mice were euthanized by cervical dislocation and sciatic nerves were removed and frozen in nitrogen immediately. The tissues were homogenized in lysis buffer (Millipore) with phosphatases (Sigma) and proteases inhibitors (Roche, Basel, Switzerland), using a dounce homogenizer (Sigma). Protein concentration was determined by BCA assay (Thermo Sciem-tific, Rockford, IL, USA). Samples of 20 g protein were applied to SDS-PAGE gels (Invitrogen) and blotted onto PDVF membrane (Millipore). Membranes were incubated with primary antibodies (1:1000) overnight at 4°C. Primary antibodies against the following proteins were used for Western blot: collagen VI (rabbit polyclonal; Fitzgerald); ␤-III tubulin, ␤-actin (mouse monoclonal; Sigma); neurofilament (mouse monoclonal; Abcam); phospho-neurofilament (mouse monoclonal; Covance); Bax, FAK, JNK, vimentin (rabbit polyclonal; Santa Cruz Biotechnology, Santa Cruz, CA, USA); phospho-JNK (mouse monoclonal; Santa Cruz); peripherin (rabbit polyclonal; Novus); AKT, caspase-9, phospho-c-Jun, CNPase, phospho-FAK (rabbit polyclonal; Cell Signaling); MBP (rat monoclonal; Abcam); phospho-AKT, Bcl-2, Bcl-X L , c-Jun, ERK, phospho-ERK, myelin-associated glycoprotein (MAG), p38, and phospho-p38 (rabbit monoclonal; Cell Signaling). After being washed 3 times with TBST, membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (1:1000; Amersham Bioscience, Dübendorf, Switzerland) for 1 h at room temperature. Detection was by chemiluminescence (Pierce, Rockford, IL, USA). Densitometric quantification was performed by Image-Pro Plus 6.0 software (Media Cybernetics).
Electrophysiology
Electrophysiological measurements were performed as described previously (28 -30) . Briefly, mice were anesthetized with ketamine (100 mg/kg body weight) and xylazine (8 mg/kg body weight). The body temperature of mice was adjusted to 37°C using a heating pad, which was continuously monitored by the thermal probe of a Peltier warming system (NPI, Tamm, Germany). Monopolar stainless steel needle electrodes (28 gauge; Grass-Astromed, West Warick, RI, USA) were used both as stimulating and recording electrodes. For stimulation, a pair of stimulating electrodes was placed along the nerve at the sciatic notch nerve (proximal stimulation), and a second pair of electrodes was placed along the tibial nerve above the ankle (distal stimulation). A recording electrode was inserted in muscles in the middle of the paw, while the reference electrode was subcutaneously inserted between the first and second digits. Square pulses of fixed duration (0.5 ms), delivered by a stimulator (Grass S88; Grass-Astromed) through a stimulus isolator unit (SIU 5; GrassAstromed), were used to stimulate the nerve. The intensity of stimuli was adjusted to obtain supramaximal nerve stimulation. The compound muscle action potential (CMAP), recorded from the paw muscles using electrodes, was amplified using an extracellular amplifier (Grass P6; Grass-Astromed), displayed on a digital oscilloscope (Tektronix, Beaverton, OR, USA) for online view, and fed to a PC with an A/D interface (Norton Instruments), for storage and offline analysis, using appropriate software (pClamp 9, Axon; WinEDR, University of Strathclyde, Glasgow, Scotland). Nerve conduction velocities (NCVs) were calculated as the distance divided by the difference between the proximal and distal stimulation latencies.
Behavioral tests
The rotarod test was performed placing mice on a rotating rod (Ugo Basile, Comerio, Italy) at a fixed speed of 30 rpm. After three 2-min training trails for 2 d, the latency to fall off the rotating rod was recorded. The ledged beam test was performed by putting mice on a suspended 1 m long runway with a 6 cm width at the starting point, then gradually narrower to 0.5 cm. The distance from the start to the point where first foot fault occurred was measured, and the total number of hind foot faults was recorded. For the footprint test, gait was examined by applying nontoxic paint to hindpaws (green) and forepaws (black). Mice were placed on white paper, and stride width, stride difference, and angles were recorded. The stride difference was calculated by subtracting the shortest stride from the longest stride, and angles were measured between foot steps and walking direction. The hotplate test was performed by placing mouse in a heated hotplate chamber (55°C; Thermomix 1419; B. Braun Melsungen AG, Melsungen, Germany). The latency to distressful behavior, such as paw licking and squeaking, was recorded for each mouse. The von Frey filament test was performed by placing mouse in suspended plastic chambers with a perforated metal sheet for 0.5 h before testing. A series of calibrated von Frey hairs (North Coast Medical, Morgan Hill, CA, USA) was applied perpendicularly to the plantar surface of the hindpaw. The pain threshold was determined as the lower force that evoked a withdrawal response to 3 out of the 5 stimuli. The withdrawal threshold of each mouse was expressed as the average threshold of left and right hindpaws.
Statistical analysis
Data are presented as means Ϯ se. Statistical analysis of data was carried out using the Student's t test, except for the analysis of H reflex, where the 2 test was used. Values of P Ͻ 0.05 were considered significant.
RESULTS
Schwann cells contribute to collagen VI deposition in sciatic nerve
To analyze the deposition of collagen VI in peripheral nerves, we labeled murine sciatic nerves with specific antibodies against collagen VI. Immunofluorescence showed that collagen VI was abundant in the endoneurium of sciatic nerve and located outside of myelin as demonstrated by labeling for MBP, a major constituent of Schwann cell myelin sheaths (Supplemental Fig.  S1A ). Collagen VI was not colocalized with neurofilaments but partially colocalized with S100 (Schwann cell marker) and NGFR p75 (nonmyelinating Schwann cell marker), suggesting that collagen VI is produced by Schwann cells but not by axons ( Fig. 1A-C) , as also confirmed by collagen VI labeling in teased fiber (Supplemental Fig. S1B ). Immunofluorescence for CD68, a marker for macrophages, the major type of resident immune cells in the PNS, showed partial colocalization with collagen VI (Fig. 1D ), suggesting that macrophages may also produce collagen VI in sciatic nerve. Blood-derived macrophages are known to express and secrete collagen VI depending on their activation status and differentiation stage (31) . However, the restricted number of macrophages present in sciatic nerve is not activated under physiological conditions, suggesting that macrophages have a limited contribution on collagen VI deposition in sciatic nerve. We then further examined the in vitro deposition of collagen VI by Schwann cells. Both immunofluorescence and Western blot showed that collagen VI was abundantly produced by RT4-D6P2T Schwann cells (Fig. 1E , F) and primary Schwann cells (Fig. 1G, H) . Taken together, these data indicate that Schwann cells contribute to collagen VI deposition in the sciatic nerve.
Lack of collagen VI leads to axon hypermyelination in the sciatic nerve
To assess the function of collagen VI in peripheral nerves, we utilized Col6a1 Ϫ/Ϫ mice. Col6a1 Ϫ/Ϫ sciatic nerves did not show any labeling for collagen VI (Supplemental Fig. S2 ), indicating that ablation of the ␣1(VI) chain leads to loss of collagen VI in peripheral nerves.
Light microscopy of sciatic nerves of 6-to 7-mo-old mice after toluidine blue staining showed that the total number of fibers ( Fig. 2A, B) and the distribution of various fiber types ( Fig. 2A, C) were not affected by lack of collagen VI. The myelin sheath of most collagen VI-null fibers appeared thicker than that of control fibers ( Fig. 2A) , and the mean g-ratio (i.e., the ratio between axon diameter and the diameter of fiber including myelin) of collagen VI-null fibers was significantly decreased when compared with controls (Fig.  2D) . Interestingly, the g ratio of Col6a1
Ϫ/Ϫ nerves was decreased in all classes of fibers as indicated by the analysis of g-ratio within classes of fibers binned for their axonal diameter (Fig. 2E) . The increased myelination of Col6a1 Ϫ/Ϫ sciatic nerves was also supported by electron microscopy (Fig. 2F, G) and by analyzing myelin associated proteins. Indeed, immunofluorescence and Western blot showed that MBP levels were significantly increased in Col6a1 Ϫ/Ϫ nerves compared with controls (Fig. 2H, I ). Moreover, Western blot for MAG and CNPase and immunofluorescence for S100 showed that the levels of all these proteins were markedly increased in Col6a1 Ϫ/Ϫ nerves compared with controls ( Fig. 2J and Supplemental Fig. S3A, B) . Electron microscopy analysis of longitudinal section of sciatic nerves showed that the myelin sheaths are uniformly hypermyelinated in Col6a1 Ϫ/Ϫ mice (Fig. 2G ). To further examine whether collagen VI regulates myelination in vitro, we cultured RT4-D6P2T Schwann cells in the absence or in the presence of purified native collagen VI, used as a coating substrate in the culture dishes. Western blot showed that addition of collagen VI reduced MAG expression in Schwann cells (Supplemental Fig. S3C ). These data indicate that lack of collagen VI leads to increased myelination and provide the first evidence that collagen VI is a crucial factor in peripheral nerve myelination.
We then examined whether the increased myelination of Col6a1 Ϫ/Ϫ nerves was present at earlier time points, during postnatal development. However, analysis of 2-to 3-mo-old mice did not reveal significant differences in myelin thickness between wild-type and Col6a1 Ϫ/Ϫ sciatic nerves (Supplemental Fig. S4 ). Therefore, we chose 6-to 7-mo-old mice for following studies. We next evaluated whether lack of collagen VI induces any compensatory change in axons. Western blot showed comparable ␤-III tubulin, neurofilament, and phospho-neurofilament levels in wild-type and Col6a1 Ϫ/Ϫ sciatic nerves (Fig. 3A, B) . ␤-III tubulin immunofluorescence did not show any noticeable difference between wild-type and Col6a1 Ϫ/Ϫ sciatic nerve axons (Fig. 3C) . When peripheral nerves are injured, inflammatory cells, such as macrophages, are rapidly recruited to the damage site (32) . To further confirm that axons were not damaged in Col6a1 Ϫ/Ϫ mice, we assessed the amount of inflammatory cells in sciatic nerves. Immunofluorescence for markers of inflamma- tory cells showed that the number of CD68 ϩ macrophages and CD45 ϩ inflammatory cells was not significantly different between wild-type and Col6a1 Ϫ/Ϫ sciatic nerves (Fig. 3D, E) , thus confirming that axons remain intact in Col6a1 Ϫ/Ϫ sciatic nerves. Our previous studies indicated that lack of collagen VI causes spontaneous apoptosis in muscles (23) . We therefore investigated apoptosis in the sciatic nerve of both genotypes. Although the amounts of procaspase-9 and cleaved caspase-9 were increased, the protein levels for Bcl-2, an antiapoptotic factor, were also increased in Col6a1 Ϫ/Ϫ sciatic nerve when compared with controls (Fig. 4A, B) . Interestingly, Bcl-X L and Bax protein levels were not significantly affected by collagen VI ablation (Fig. 4C, D) . Moreover, immunofluorescence for cleaved caspase-3 and TUNEL assay did not show any significant difference between control and Col6a1 Ϫ/Ϫ nerves (Fig. 4E, F) . Altogether, these findings indicate that lack of collagen VI induces increased axon myelination but does not lead to spontaneous apoptosis in the sciatic nerve.
Molecular signals involved in PNS myelination are altered in Col6a1
؊/؊ nerves
To characterize the molecular basis of the abnormal myelination of peripheral nerves caused by collagen VI deficiency, we analyzed signaling pathways involved in the regulation of PNS myelination and function. Activation of FAK (33), AKT (34 -36) , ERK (37, 38) , and p38 MAP kinase (39, 40) is required for axon myelination in the PNS. In agreement with the increased myelination of Col6a1 Ϫ/Ϫ sciatic nerves, collagen VI deficiency was accompanied by higher phosphorylation levels of FAK, AKT, ERK, and p38 (Fig. 5A-D) . On the other hand, myelination is negatively regulated by vimentin (34) , as well as by the JNK and c-Jun pathways (41) . Western blot for vimentin, phospho-JNK, and phospho-c-Jun showed that they were significantly decreased in Col6a1 Ϫ/Ϫ nerves ( Fig. 5E-G) . To further examine whether collagen VI impinges on Schwann cell signals involved in the regulation of myelination, we treated RT4-D6P2T Schwann cells with exogenous collagen VI. Western blot showed that addition of collagen VI rapidly promotes c-Jun phosphorylation in Schwann cells (Fig. 5H ), in agreement with the in vivo finding of decreased levels of phospho-c-Jun in Col6a1 Ϫ/Ϫ nerves. These findings support the hypermyelinated phenotype of collagen VI-deficient nerves, indicating abnormal regulation of molecular pathways involved in the control of myelination.
Col6a1
؊/؊ mice display defective nerve conduction velocity and impaired motor coordination To get insight into the functional significance of the structural PNS defects observed in Col6a1 Ϫ/Ϫ mice, we performed electrophysiology experiments in sciatic nerves. Representative traces of wild-type and Col6a1 Ϫ/Ϫ mice are shown in Fig. 6A . CMAP amplitudes were slightly (albeit not significantly) reduced in Col6a1 Ϫ/Ϫ mice with respect to controls, both after proximal and distal stimulation (Fig. 6B) . Notably, Col6a1 Ϫ/Ϫ mice displayed a significant decrease of NCVs when compared with wild-type mice (Fig. 6C) . NCVs are influenced by Schwann cell internodal length and nodal integrity (42, 43) . Thus, we examined whether internodal length and nodal integrity were changed in collagen VI-null nerves. In agreement with the decreased NCVs, we found that the internodal length was dramatically decreased in Col6a1 Ϫ/Ϫ mice when compared with controls (Fig. 6D) . However, the nodal integrity was not affected by the deficiency of collagen VI (Fig. 6E) . These results indicate that the abnormal myelination of Col6a1 Ϫ/Ϫ peripheral nerves is matched by reduced NCVs and decreased internodal length, pointing at functional deficits in collagen VI-deficient mice.
Next, we analyzed the motor function of collagen VI-deficient mice. Wild-type and Col6a1 Ϫ/Ϫ mice showed similar performances in the rotarod test (Fig. 7A) , suggesting no major impairment of the general motor function in collagen VI-deficient mice. Conversely, when subjected to the ledged beam-walking test, the distance of first footslip was significantly decreased in Col6a1 Ϫ/Ϫ mice when compared with wild-type mice (Fig. 7B) . Moreover, the total number of hind footslips was dramatically increased in Col6a1 Ϫ/Ϫ mice (Fig. 7C) , suggesting that motor coordination and balance are impaired in collagen VI-deficient mice. Footprint analysis showed no significant difference in the stride width between wild-type and Col6a1 Ϫ/Ϫ mice (Fig. 7D, E) . Nevertheless, the stride length variability of hindlimbs was increased in Col6a1 Ϫ/Ϫ mice (Fig. 7D, F) , indicating increased gait instability in collagen VI-deficient mice. Furthermore, the angle between foot steps and walking direction of hindlimbs was wider in Col6a1 Ϫ/Ϫ mice compared with wild-type mice (Fig. 7D, G) , pointing at an impairment of motor coordination in Col6a1 Ϫ/Ϫ mice. Taken together, these data demonstrate that collagen VI deficiency leads to the impairment of motor coordination and balance in mice.
Collagen VI-deficient mice display defective sensory function
As shown by the electrophysiological analysis, we found that a clear H reflex was elicited following both proxi- mal and distal stimulation in all 8 wild-type mice but only in 1 out of 8 Col6a1 Ϫ/Ϫ mice ( Fig. 6A and Table 1 ), indicating a sensory deficit in Col6a1 Ϫ/Ϫ mice. Moreover, the sole Col6a1 Ϫ/Ϫ mouse with H reflex response showed enhanced latency when compared with controls ( Table 1) .
Nonmyelinating Schwann cells always engulf C fibers, which are high-threshold nociceptors. Thermal hot pain is predominantly transduced by C fibers (44) , which transmit impulses from the periphery, through dorsal root ganglia (DRGs), the primary sensory neurons, into the dorsal horn of spinal cord (45) . Therefore we investigated the role of collagen VI on C-fiber organization by transmission electron microscopy. C fibers in Col6a1 Ϫ/Ϫ nerves were disorganized, displaying larger axons than in wild-type nerves (Fig. 8A) , thus suggesting altered sensory function in Col6a1 Ϫ/Ϫ mice. Next, we evaluated the expression of peripherin, a nociceptive neuron marker, in Col6a1 Ϫ/Ϫ mice. Western blot and immunofluorescence revealed that the levels of peripherin were markedly reduced in the sciatic nerves, in the DRGs, and in the superficial layers of spinal cord of Col6a1 Ϫ/Ϫ mice when compared with the corresponding wild-type samples (Fig. 8B-D) , indicating that nociceptive signals are decreased in Col6a1 Ϫ/Ϫ mice. We then investigated the sensory function in collagen VI-null mice using thermal and mechanical stimuli as measured by hotplate and von Frey filament test, respectively. The sensitivity to both thermal and mechanical stimuli was significantly decreased in
Col6a1
Ϫ/Ϫ mice compared with wild-type mice (Fig. 8E,  F) , indicating a delay in nociception. These results suggest that collagen VI is also required for peripheral nerve function in stressful conditions.
DISCUSSION
In this study, we describe for the first time that collagen VI contributes to the structural integrity and physiological functions of peripheral nerve. We provide evidence for histopathological and cellular phenotypes with increased myelin thickness in the peripheral nerve of Col6a1 Ϫ/Ϫ mice, leading to a functional phenotype with impairment of NCVs, motor coordination, and sensory transduction. Furthermore, we show that collagen VI regulates myelin thickness by modulating myelinationrelated signaling pathways.
A proper thickness of myelin is required for the correct transmission of electrical impulses along the axons and for preservation of axonal integrity in PNS. The increased myelination detected in Col6a1 Ϫ/Ϫ mice provides the first evidence that collagen VI is a crucial factor in peripheral nerve myelination in vivo. Collagen VI is an abundant ECM protein of peripheral nerves (18, 46) . Previous studies indicated that Col6 genes are abundantly expressed by Schwann cells in peripheral nerves (21, 47 ). In the current study, we provided both in vivo and in vitro evidence that collagen VI is produced by Schwann cells and macrophages but not deposited by axons of sciatic nerves. Furthermore, ablation of collagen VI does not induce any significant change in axon and macrophage density in sciatic nerves. These data suggest that the hypermyelination of Col6a1 Ϫ/Ϫ nerves is a Schwann cell-related defect and point at collagen VI as an ECM molecule involved in the regulation of Schwann cells myelination in vivo. On the other hand, collagen VI is considered as a cell prosurvival factor, since collagen VI deficiency induces apoptosis in muscle (23) and enhances neuron death on toxic treatments in the central nervous system (19, 20) . Nevertheless, we did not find any difference between wild-type and Col6a1 Ϫ/Ϫ mice in the incidence of spontaneous apoptosis of peripheral nerves. This may be explained considering that collagen VI forms different structures in different tissues (17) , thus exerting potentially distinct functions. The underlying mechanisms for the different prosurvival effects exerted by collagen VI in different tissues will require further investigations in the future.
Understanding the molecular machinery that regulates myelination is crucial for developing new potential strategies to control the proper myelination. Vimentin is an intermediate filament protein that is expressed in both Schwann cells and neurons and functions as a negative regulator of peripheral nerve myelination through the AKT pathway (34) . In our study, we observed increased AKT phosphorylation and decreased vimentin expression in Col6a1 Ϫ/Ϫ nerves. Hence, the increased myelination induced by collagen VI deficiency is partly modulated by activation of AKT signal pathway. C-jun and FAK are 2 important signals in Schwann cells, which exert distinct roles in the inhibition (41) or promotion (33) of myelination in peripheral nerves, respectively. Interestingly, we found that in Col6a1 Ϫ/Ϫ nerves phospho-JNK is reduced, whereas phospho-FAK is increased. These results highlight the involvement of both positive and negative myelination regulatory pathways in mediating collagen VI deficiency-induced hypermyelination in peripheral nerves. The function of ERK (32, 37, 38, 48) and p38 (39, 40, 49) signals in peripheral myelination is still controversial. Our results show that ERK and p38 signals are activated in Col6a1 Ϫ/Ϫ nerves, which support the concept that both signals positively regulate myelination. The observed altered signaling pathways in sciatic nerves of Col6a1 Ϫ/Ϫ mice provide mechanistic insight into the role of collagen VI in axonal myelination. Our findings in collagen VI-deficient mice, together with the fact that collagen VI is produced by Schwann cells, suggest that the hypermyelination of Col6a1 Ϫ/Ϫ nerves is Schwann cell autonomous. Further investigations using in vivo models with Schwann cellspecific conditional deficiency of collagen VI will allow addressing such mechanistic aspects in the future.
Abnormal myelin thickness is closely related with motor dysfunction in animals and peripheral neuropa- Ϫ/Ϫ mice (D; black, forepaws; green, hindpaws), quantification of the stride width of forelimbs and hindlimbs (E), quantification of stride variability of forelimbs and hindlimbs (F), and measurement of foot-to-walk axis in wild-type and Col6a1 Ϫ/Ϫ mice (G). **P Ͻ 0.01; *P Ͻ 0.05; n ϭ 4.
thies in human (4 -7). Our results show that ablation of collagen VI induces increased PNS myelination in vivo with an impairment of motor coordination. This may seem to be in contradiction with the general opinion that myelin is required for the transmission of electric impulse and that PNS demyelination is related to the impairment of motor functions in animals (50) and humans (4 -6) . However, myelin thickness needs to be properly maintained and axonal hypermyelination can increase the proportion of the surrounding wire volume, thus altering biophysical properties and axonal functions (51) . Indeed, hypermyelination was found to be associated with defective axonal function in several murine models. In a mouse model of adrenomyeloneuropathy with inactivation of the X-ALD gene, focal hypermyelination of sciatic nerve is accompanied by impaired motor coordination activity and electrophysiological alterations in nerve conduction (7) . Similarly, ablation of the ZPR1 zinc finger protein induces focal hypermyelination in peripheral nerves and motor function defects in mice (52) . Furthermore, clinical evidence showed that laminin ␣2 chain deficiency-induced neuropathy is also related to nerve hypermyelination (53) . These findings strongly support our results that the increased myelination of collagen VI-deficient sciatic nerves is accompanied by motor function alterations. Moreover, nerve electrophysiology studies showed that the NCVs are significantly reduced in Col6a1 Ϫ/Ϫ mice, which on the one hand supports the impairment of motor function, whereas on the other hand may suggest a possible axon damage induced by the increased myelination. However, our data indicate that there is no evidence for axon damage or inflammation in collagen VI-null nerves, thus excluding their contribution in the decreased NCVs of Col6a1 Ϫ/Ϫ mice. NCVs are also influenced by Schwann cell internodal length (42, 43) . In agreement with the decreased NVC, we found that the internodal length is dramatically decreased in Col6a1 Ϫ/Ϫ sciatic nerves. Together, these results not only point at collagen VI as an important factor for axonal myelination and motor function but also support the concept that proper myelination is required for the function of peripheral nerves.
The defective PNS function in Col6a1 Ϫ/Ϫ mice is also apparent in stressful conditions, such as in the hotplate and von Frey filament tests, indicating that the acute nociceptive response is delayed in collagen VI-deficient mice. Our ultrastructural analysis shows that C fibers are disorganized in Col6a1 Ϫ/Ϫ sciatic nerve, a defect paralleled by decreased expression of the C-fiber marker peripherin in the sciatic nerves, DRGs and superficial layers of spinal cord, as well as delayed pain response in Col6a1 Ϫ/Ϫ mice. These data suggest that collagen VI is also required for the peripheral nerve function in stressful conditions. Our findings of decreased motor and sensory functions in collagen VI null mice indicate that collagen VI plays a critical role in the PNS. Similar motor and sensory deficits were described in mice lacking von Willebrand A domain-related protein (18) , as well as in Col15a1
Ϫ/Ϫ doubleknockout mice (8) . Altogether, our findings support collagen VI as a key regulator in peripheral nerve function.
In summary, we found that lack of collagen VI causes structural abnormalities in peripheral nerves, leading to functional defects in NCVs, motor coordination, and nociception. This is the first evidence demonstrating that collagen VI plays a pivotal role in axonal myelination, C-fiber organization, and peripheral nerve function. Until now, collagen VI was linked to different forms of genetic muscle diseases, such as Ullrich congenital muscular dystrophy, Bethlem myopathy, and congenital myosclerosis (15) . Interestingly, a possible clinical implication for collagen VI in the nervous compartment was indicated by the evidence that collagen VI is significantly increased in the endoneurium and perineurium of peripheral nerves in diabetic neuropathy patients (54, 55) and by a very recent study where a mutation of the COL6A2 gene was found in a consanguineous family affected by progressive myoclonus epilepsy (56) . Our results in the collagen VI-deficient mouse model open the possibility that collagen VI may be involved in the onset and/or progression of human peripheral neuropathies and that it may represent a novel target for the development of therapeutic approaches for peripheral neuropathies. axons from 3 wild-type mice; n = 1844 axons from 4 Col6a1 -/-mice). WT, wild-type.
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